What are the hottest jobs in biotech?; Bayer's Xarelto "highly effective" in preventing recurrent stroke;

@FierceBiotech: Successes, failures mark 30 years of HIV/AIDS research. Feature | Follow @FierceBiotech

@JohnCFierce: Novartis racks up more positive Ph3 data on Ilaris and analysts seem bullish about the mab's blockbuster chances. Article | Follow @JohnCFierce

> Anyone looking to get a job in the life sciences should explore systems biology and bioinformatics, notes BioWorld as it looks at the hottest jobs in biotech. Story

> Bayer and J&J say that a subgroup analysis of Phase III Xarelto data indicates that "rivaroxaban is highly effective in the prevention of recurrent strokes in patients with atrial fibrillation who have experienced a prior stroke or transient ischemic attack. Bayer release

> Vyteris reportedly wants out of the drug delivery side of the business as it plots a new strategy of building its CRO business through new acquisitions. Report 

> Pathway Therapeutics says it has garnered $7.5 million in new funding as well as the FDA's acceptance of its IND filing for PWT33597. Release

Reuters takes a look at Nestle's buyout of Prometheus, tracking the interconnecting lines between Big Pharma and Big Food. Report

> San Diego-based Trius Therapeutics has priced a $30 million offering. Trius release

> Achillion reports that it has begun dosing in a Phase 1 clinical trial of ACH-2684, a novel pan-genotypic protease inhibitor being developed for the treatment of chronic hepatitis C virus. Achillion release

Pharma News

@FiercePharma: The 12 greenest companies in biopharma. Report | Follow @FiercePharma

> UCB to pit Cimzia against Humira in arthritis study. Article

> Vertex to field small, specialized sales force on Incivek. Story

> New Novartis MS pill racks up 10,000 U.S. users. Report

Drug Delivery News

> Low-level electrical current delivers long-lasting drugs in the eye. Piece

> Phosphagenics, 3M a step closer to oxycodone patch. Item

> PolyPid's drug-delivery tech combines polymers and lipids. Story

> Vyteris wants to give up the drug-delivery ghost. Item

> Venus Remedies gets EU patent for painkiller injection. Report

> KemPharm's painkiller reduces constipation, abuse risk. Article

Medical Device News

> Covidien launches compliance resource for HCPs. Piece

> Study: Medtronic's Infuse can increase male infertility risk. Story

> Kensey Nash picks up Norian assets. News

> Smith out as Angeion CEO. Report

And Finally... World Health officials are once again putting off any decision on whether or not it will demand that the U.S. destroy the remaining stockpile of smallpox. The years-long debate has pitted advocates who want to see it eliminated once and for all against researchers who insist they need the supply to develop new treatments that could fight a synthesized version of smallpox. Report

Suggested Articles

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…

In this week's EuroBiotech Report, Lundbeck inks $2 billion Alder buyout, Euro biotechs raise cash and blast rocks Russian smallpox lab.